282 related articles for article (PubMed ID: 34836524)
1. A machine learning based two-stage clinical decision support system for predicting patients' discontinuation from opioid use disorder treatment: retrospective observational study.
Hasan MM; Young GJ; Shi J; Mohite P; Young LD; Weiner SG; Noor-E-Alam M
BMC Med Inform Decis Mak; 2021 Nov; 21(1):331. PubMed ID: 34836524
[TBL] [Abstract][Full Text] [Related]
2. An explainable machine learning framework for predicting the risk of buprenorphine treatment discontinuation for opioid use disorder among commercially insured individuals.
Al Faysal J; Noor-E-Alam M; Young GJ; Lo-Ciganic WH; Goodin AJ; Huang JL; Wilson DL; Park TW; Hasan MM
Comput Biol Med; 2024 Jul; 177():108493. PubMed ID: 38833799
[TBL] [Abstract][Full Text] [Related]
3. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
4. Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts.
Hasan MM; Noor-E-Alam M; Mohite P; Islam MS; Modestino AS; Peckham AM; Young LD; Young GJ
J Subst Abuse Treat; 2021 Dec; 131():108416. PubMed ID: 34098294
[TBL] [Abstract][Full Text] [Related]
5. Predicting Patient Satisfaction With Medications for Treating Opioid Use Disorder: Case Study Applying Natural Language Processing to Reviews of Methadone and Buprenorphine/Naloxone on Health-Related Social Media.
Omranian S; Zolnoori M; Huang M; Campos-Castillo C; McRoy S
JMIR Infodemiology; 2023; 3():e37207. PubMed ID: 37113381
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
Samples H; Williams AR; Olfson M; Crystal S
J Subst Abuse Treat; 2018 Dec; 95():9-17. PubMed ID: 30352671
[TBL] [Abstract][Full Text] [Related]
7. Creation of an algorithm for clinical decision support for treatment of opioid use disorder with buprenorphine in primary care.
Dela Cruz AM; Walker R; Pipes R; Wakhlu S; Trivedi MH
Addict Sci Clin Pract; 2021 Feb; 16(1):12. PubMed ID: 33608060
[TBL] [Abstract][Full Text] [Related]
8. Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?
Meinhofer A; Williams AR; Johnson P; Schackman BR; Bao Y
J Subst Abuse Treat; 2019 Oct; 105():37-43. PubMed ID: 31443889
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
[TBL] [Abstract][Full Text] [Related]
10. Understanding Opioid Use Disorder (OUD) using tree-based classifiers.
Wadekar AS
Drug Alcohol Depend; 2020 Mar; 208():107839. PubMed ID: 31962227
[TBL] [Abstract][Full Text] [Related]
11. Identifying risk of opioid use disorder for patients taking opioid medications with deep learning.
Dong X; Deng J; Rashidian S; Abell-Hart K; Hou W; Rosenthal RN; Saltz M; Saltz JH; Wang F
J Am Med Inform Assoc; 2021 Jul; 28(8):1683-1693. PubMed ID: 33930132
[TBL] [Abstract][Full Text] [Related]
12. Prediction of In-hospital Mortality in Emergency Department Patients With Sepsis: A Local Big Data-Driven, Machine Learning Approach.
Taylor RA; Pare JR; Venkatesh AK; Mowafi H; Melnick ER; Fleischman W; Hall MK
Acad Emerg Med; 2016 Mar; 23(3):269-78. PubMed ID: 26679719
[TBL] [Abstract][Full Text] [Related]
13. Predictability of buprenorphine-naloxone treatment retention: A multi-site analysis combining electronic health records and machine learning.
Nateghi Haredasht F; Fouladvand S; Tate S; Chan MM; Yeow JJL; Griffiths K; Lopez I; Bertz JW; Miner AS; Hernandez-Boussard T; Chen CA; Deng H; Humphreys K; Lembke A; Vance LA; Chen JH
Addiction; 2024 Jun; ():. PubMed ID: 38923168
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning Approaches to Predict Chronic Lower Back Pain in People Aged over 50 Years.
Shim JG; Ryu KH; Cho EA; Ahn JH; Kim HK; Lee YJ; Lee SH
Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833448
[No Abstract] [Full Text] [Related]
15. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
[TBL] [Abstract][Full Text] [Related]
16. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
17. Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study.
Lo-Ciganic WH; Huang JL; Zhang HH; Weiss JC; Kwoh CK; Donohue JM; Gordon AJ; Cochran G; Malone DC; Kuza CC; Gellad WF
PLoS One; 2020; 15(7):e0235981. PubMed ID: 32678860
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions.
Lo-Ciganic WH; Huang JL; Zhang HH; Weiss JC; Wu Y; Kwoh CK; Donohue JM; Cochran G; Gordon AJ; Malone DC; Kuza CC; Gellad WF
JAMA Netw Open; 2019 Mar; 2(3):e190968. PubMed ID: 30901048
[TBL] [Abstract][Full Text] [Related]
19. Adherence to buprenorphine: An analysis of prescription drug monitoring program data.
Pizzicato LN; Hom JK; Sun M; Johnson CC; Viner KM
Drug Alcohol Depend; 2020 Nov; 216():108317. PubMed ID: 33035714
[TBL] [Abstract][Full Text] [Related]
20. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
